BioNTech SE Stock Latest News

BioNTech (BNTX) wants to bring a mRNA vaccine to the fight against malaria. The company aims to develop...

In a report issued on July 20, Daina Graybosch from Leerink Partners maintained a Hold rating...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh...

According to a report by CNN, the U.S. Food and Drug Administration (FDA) has granted priority review designation...

German biotechnology firm BioNTech SE (BNTX) has revealed that the first patient has been dosed in its Phase...

New Zealand has tentatively cleared the COVID-19 vaccine that Pfizer (PFE) developed in partnership with BioNTech (BNTX) for...

Notwithstanding the horrors of the novel coronavirus pandemic, one definitive bright spot that emerged is the rapid-fire development...

BioNTech SE (BNTX) and its partner Pfizer (PFE) have received Conditional Marketing Authorization (CMA) in the E.U. for...

Pfizer (PFE) and BioNTech (BNTX) have agreed to supply 900 million doses of their COVID-19 vaccine, COMIRNATY, to...

BioNTech SE (BNTX) is expanding its global footprint by entering the Asian market. The company will set up...

Pfizer Inc and BioNTech SE have inked an agreement to supply 200 million additional doses of their COVID-19...

Pfizer-BioNTech’s COVID-19 vaccine has been cleared by Australia’s health regulator to be used for immunization in individuals aged...

Pfizer and BioNTech’s coronavirus vaccine may be effective in neutralizing rapidly spreading variants of SARS-CoV2 that have developed...

Pfizer and its German partner BioNTech are planning to offer the first dose of its investigational COVID-19 vaccine...

Pfizer and German partner BioNTech (BNTX) have won another order from the European Union to supply an additional...

Pfizer and German partner BioNTech have won a second order with the US government for the supply of...

Pfizer and German partner BioNTech announced that the European Commission (EC) has granted a conditional marketing authorization (CMA)...

Pfizer and German partner BioNTech will start distribution of the first doses of its BNT162b2 in Switzerland after...

BioNTech and Shanghai Fosun Pharmaceutical announced an agreement for the supply of an initial 100 million doses of...

Pfizer and German partner BioNTech announced that they will start distributing the first batches of their BNT162b2 vaccine...

Shares of Pfizer and BioNTech rose in Thursday’s extended market session after an advisory panel to the US...

Pfizer Inc. and BioNTech’s mRNA vaccine candidate, BNT162b2, against COVID-19, was found to be safe and effective, according...

Last week, the UK became the first western country to begin the rollout of a COVID-19 vaccine. The...

Pfizer Inc. and its German partner BioNTech will start to supply the UK with their mRNA vaccine from...

Pfizer Inc. and its German partner BioNTech have filed a formal application to the European Medicines Agency (EMA)...

Unfortunately, Covid-19 is still on the rampage across the globe. However, the good news is that the newest...

The US Food and Drug Administration (FDA) will review Pfizer Inc. and BioNTech’s request for emergency use authoriziation...

The past couple of weeks have seen extremely promising developments in the Covid-19 vaccine space. Both Pfizer (PFE)/BioNTech...

Pfizer Inc. and its German partner BioNTech are planning to apply for US emergency use authorization (EUA) for...

Pfizer Inc has kicked off a pilot delivery program for its COVID-19 vaccine candidate in four US states,...

BioNTech and Shanghai partner Fosun Pharma have been granted regulatory approval to commence the clinical trial for their...

Pfizer (PFE) and BioNTech SE have won a contract to supply European Union (EU) Member States with 300 million...

The recent coronavirus vaccine race has been fraught with setbacks. Both Astra Zeneca and Johnson & Johnson recently...

Pfizer is planning to file an application to the U.S. Food and Drug Administration (FDA) for approval of...

And they’re off to the races. BioNTech (BNTX) and its partner, Pfizer (PFE), which are among those racing...

Pfizer and BioNTech (BNTX) will provide 1.5 million COVID-19 vaccine doses to the New Zealand government following a...

Pfizer’s (PFE) Pfizer Canada and BioNTech SE have announced the initiation of a rolling submission to Health Canada for...

BioNTech has clinched an agreement with Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for...

Pfizer and BioNTech SE announced on Tuesday that the European Medicines Agency (EMA) has put BNT162b2, their mRNA-based vaccine...

BioNTech has signed an agreement to buy a new manufacturing site in Germany from Novartis AG in a...

The world needs a vaccine against COVID-19, and with some 200 vaccine candidates in various stages of development,...

Pfizer’s (PFE) vaccine candidate BNT162b2 could be available to Americans by the end of the year if the...

Pfizer and BioNTech announced that they have proposed the expansion of the enrollment in their Phase 3 pivotal...

Just eight days after AstraZeneca (AZN) announced the expansion of clinical trials of its AZD1222 vaccine against coronavirus...

Pfizer (PFE) and BioNTech SE have concluded exploratory talks with the European Commission for a proposed supply of 200 million...

BioNtech (BNTX) is one of the companies at the front-line of the battle against the coronavirus. On Friday,...

Pfizer Inc. and BioNTech SE disclosed “positive” data from an early trial of their BNT162b2 mRNA-based vaccine candidate...

Pfizer Inc. and BioNTech SE on Wednesday agreed to supply the Government of Canada with their BNT162 mRNA-based vaccine...

Pfizer (PFE) and BioNTech SE (BNTX) have announced the start of a global (except for China) Phase 2/3 safety and efficacy...

Pfizer Inc (PFE) and BioNTech SE (BNTX) have agreed to provide the US government with 100 million doses of their...